[Chronobiotics as potential geroprotectors.]

Area of Science:

• Chronobiology
• Gerontology
• Pharmacology

Background:

• Aging is associated with disrupted circadian regulation.
• Circadian dysfunction contributes to neurodegenerative and metabolic disorders.
• Chronobiotics modulate biological rhythms.

Purpose of the Study:

• To analyze the impact of chronobiotics on aging processes.
• To evaluate chronobiotics as potential geroprotectors.
• To identify challenges and future directions for chronobiotic use in healthy aging.

Main Methods:

• Review of existing scientific literature on chronobiotics and aging.
• Analysis of key mechanisms in circadian regulation and age-related diseases.
• Assessment of melatonin, resveratrol, and analogs as geroprotectors.

Main Results:

• Chronobiotics, including melatonin and resveratrol, show potential for geroprotection.
• Circadian rhythm mechanisms are linked to aging and related diseases.
• Clinical implementation faces challenges like chronotype variability and lack of standardization.

Conclusions:

• Chronobiotics represent a promising avenue for healthy aging interventions.
• Addressing individual factors and standardizing protocols are crucial for clinical success.
• Further research should focus on optimizing chronobiotic application for geroprotection.